A novel double-targeted nondrug delivery system for targeting cancer stem cells.
about
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.Nanomedicine applications in the treatment of breast cancer: current state of the art.Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.Increased DCLK1 correlates with the malignant status and poor outcome in malignant tumors: a meta-analysis.
P2860
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@en
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@nl
type
label
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@en
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@nl
prefLabel
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@en
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
@nl
P2093
P2860
P356
P1476
A novel double-targeted nondrug delivery system for targeting cancer stem cells
@en
P2093
Feng-Huei Lin
Shuai Geng
Shupei Qiao
Xiaolu Hou
Yufang Zhao
P2860
P304
P356
10.2147/IJN.S116230
P407
P50
P577
2016-12-08T00:00:00Z